Class Action Lawsuit Filed Against Klarna Over IPO Disclosure Claims

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Class action lawsuit filed against Klarna over IPO disclosure claims, alleging risk reserves were materially understated in regulatory filings.

Class Action Lawsuit Filed Against Klarna Over IPO Disclosure Claims

A class action lawsuit has been initiated against Klarna Group plc following its September 2025 initial public offering, with allegations centering on the accuracy of disclosures contained in the company's IPO registration statement. The legal action specifically challenges representations regarding risk reserves maintained for the company's buy-now-pay-later lending portfolio, claiming that reserves were materially understated in regulatory filings.

The lawsuit targets investors who purchased Klarna securities during the IPO period, asserting that they sustained damages based on the alleged misstatements and omissions in the offering documentation. According to the filing timeline, investors interested in participating in the class action must establish their claim as the lead plaintiff by February 20, 2026.

This action represents one of several legal challenges that BNPL providers have faced regarding financial disclosures and risk assessment practices. The outcome may have implications for how similar fintech companies report reserve adequacy and credit risk metrics to investors and regulators.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 20

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON